Natalizumab and central nervous system lymphoma: No clear association

Saved in:

Bibliographic Details
Published in:	Annals of neurology Vol. 66; no. 3; pp. 261 - 262
Main Authors:	Bozic, Carmen, LaGuette, Julia, Panzara, Michael A., Sandrock, Alfred W.
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-09-2009
Subjects:	Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Central Nervous System Neoplasms - chemically induced Central Nervous System Neoplasms - epidemiology Humans Lymphoma - chemically induced Lymphoma - epidemiology Multiple Sclerosis - drug therapy Natalizumab Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	istex:061501055B62C041AF5272F717B5568F64443B5D Potential conflict of interest: Nothing to report. ArticleID:ANA21835 ark:/67375/WNG-W9C2LT9Q-5 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0364-5134 1531-8249
DOI:	10.1002/ana.21835